Conditions · Pancreatic cancer
Pancreatic cancer — clinical trials in Finland
5 open options
- TRIALPHASE3NOT_YET_RECRUITING
Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer
mFOLFIRINOX neoadjuvant chemotherapy / Nab-paclitaxel and gemcitabine — 2 sites
- TRIALPHASE3RECRUITING
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
INCB161734 · Placebo · Investigator's choice of chemotherapy — 219 sites
- TRIALPHASE2 / PHASE3RECRUITING
Pancreatic Cancer Diagnosis With FAPI-PET Imaging
PET/CT — 1 site
- TRIALPHASE1 / PHASE2RECRUITING
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
Risvutatug Rezetecan · Drug 1 · Drug 2 — 85 sites
- TRIALPHASE4RECRUITING
Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery
enoxaparin/tinzaparin/dalteparin — 5 sites
Live from ClinicalTrials.gov, refreshed at most hourly · registry query ↗
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.